The Full Court has overturned a finding that singer Katy Perry infringed an Australian fashion designer’s ‘Katie Perry’ mark, finding the designer knew of the pop star when she registered the mark.
ASIC wants the Full Court to overturn a finding that Noumi waived privilege over a PwC report produced under a voluntary disclosure regime, arguing the regime benefits the public in making investigations more efficient.
The Commonwealth has lost its bid to pause a long-running dispute over a generic form of brand drug Abilify while the High Court hears a different generic drug battle.
The Commonwealth has argued that a long-running dispute involving drug makers Otsuka, Bristol-Myers Squibb and Generic Health should be put on ice until the High Court rules in a separate matter.
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.
The High Court has been asked to weigh in on whether the Federal Courtās prevailing approach to the disclosure requirements of the Patents Act āimposes too great a burden” on patent applicants.
Elanco Australasia has lost its bid to appeal a finding by IP Australia that a patent acquired from Bayer covering a lice treatment for livestock lacked an inventive step.
Cargill has won a trade mark infringement case against a company that a judge said appeared to be operating an āinternet scamā to intercept a $10 million payment to the multinational food company.
Seven Network has partially succeeded in appealing a decision that revoked its rights to the ‘7NOW’ trade mark for non-use, with the Full Court finding the broadcaster used the mark on its news promotion website.
In a continuing fight over damages stemming from misleading burger ads, McDonald’s has opposed production of sales information to Hungry Jack’s directors and its top executive, saying the information was confidential and the companies “fierce competitors”.